CliffBio

Thea

Patent cliffs & loss of exclusivity

5 upcoming patent cliffs

DrugIngredientTypeCliff
  1. AKTENLIDOCAINE HYDROCHLORIDESmall mol.Jul 2026
  2. ZIOPTANTAFLUPROSTSmall mol.May 2029
  3. IYUZEHLATANOPROSTSmall mol.Jul 2031
  4. ZOLYMBUSBIMATOPROSTSmall mol.Jun 2036
  5. CYKLXARTICAINE HYDROCHLORIDESmall mol.Mar 2039
  6. AZASITEAZITHROMYCINSmall mol.—
  7. BETIMOLTIMOLOLSmall mol.—
  8. BETIMOLTIMOLOLSmall mol.—
  9. COSOPTDORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATESmall mol.—
  10. COSOPT PFDORZOLAMIDE HYDROCHLORIDE; TIMOLOL MALEATESmall mol.—

Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.

Thea — patent cliffs & loss of exclusivity | CliffBio